Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-047734
Filing Date
2023-04-20
Accepted
2023-04-20 16:03:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm232007d6_defa14a.htm DEFA14A 15726
2 GRAPHIC tm232007d6_defa14aimg001.jpg GRAPHIC 238536
3 GRAPHIC tm232007d6_defa14aimg002.jpg GRAPHIC 121379
  Complete submission text file 0001104659-23-047734.txt   512769
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 23833104
SIC: 2834 Pharmaceutical Preparations